I agree, rising. The "positive" issue is that they seem to take measurements at least every 3 months. So in the open, biometric study, we may get early results as soon as some 7-8 patients have taken ATH434 for 3 -6 months (??). This is only if the company is willing to tell these results, i.e. if the results are positive. But IMO they have the early results pretty soon. Looks like they will recruit 2 patients per month so they have now perhaps 7 patients taking ATH434, the first ones already for 3 months.
The main interim outcome measures will be UMSARS, NNIPPS, NFL, and alpha-synuclein during the study, and perhaps MRI only after 12 months. These new measures in the presented poster are too new at this time.
- Forums
- ASX - By Stock
- ATH
- Ann: Alterity Presents New Data on Multiple System Atrophy
Ann: Alterity Presents New Data on Multiple System Atrophy, page-4
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 1398400 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 0.006 |
43 | 42549867 | 0.005 |
39 | 54573682 | 0.004 |
44 | 45744982 | 0.003 |
16 | 33443014 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 1398400 | 2 |
0.006 | 19503993 | 16 |
0.007 | 22172790 | 20 |
0.008 | 15048071 | 18 |
0.009 | 9032078 | 9 |
Last trade - 09.31am 16/05/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
Day chart unavailable
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online